COVID-19 Federal Responses: Thursday, June 23, 2022
A pediatrics study has revealed low vaccine efficacy towards the COVID-19 Omicron variant in teens with two vaccine doses, as opposed to teens who have receive…
Keeping up with compounding
At the FDA Annual Compounding Listening Session, a number of compounding topics were discussed, such as marketing of IV rehydration clinics.
Top 10 tips to make your practice more efficient
With declining reimbursement and rising costs, efficiency is more important than ever for allergy practices.
Promote your practice this summer
As people look for relief from their symptoms, now is a great time to promote your services as an allergist.
College raises concerns about direct-to-consumer food allergy tests
Recently, it has come to the College’s attention that Quest Direct is now offering various direct-to-consumer food allergy panel tests.
AllergyTalk: Disparities in Atopic Dermatitis Miniseries Podcasts
in AllergyTalkThis three-episode miniseries of podcasts will 1) review racial, ethnic, socioeconomic, and geographic disparities related to atopic dermatitis; 2) describe th…
ACAAI Letter to CEO of Quest Diagnostics
It has come to our attention that Quest Direct is now offering various food allergy panel tests.
COVID-19 Federal Responses: Thursday, June 16, 2022
The FDA’s Advisory Committee recommended the approval of Moderna’s COVID-19 vaccine for children under 5 years old
June’s issue of Annals focuses on allergens
In an insightful review from one of the world leaders in this field, you will get a full update on what is and what is not known about how furred animals, cock…
The AMA celebrates 175 years
The AMA celebrates 175 years of service to the medical community this year, and the College has had a long-standing partnership with the organization.